| Literature DB >> 33809172 |
Juan Sainz1,2,3,4, Francisco José García-Verdejo5, Manuel Martínez-Bueno6, Abhishek Kumar7,8,9, José Manuel Sánchez-Maldonado1,2,3, Anna Díez-Villanueva10, Ludmila Vodičková11,12,13, Veronika Vymetálková11,12,13, Vicente Martin Sánchez14,15, Miguel Inacio Da Silva Filho7, Belém Sampaio-Marques16,17, Stefanie Brezina18, Katja Butterbach19, Rob Ter Horst20, Michael Hoffmeister21, Paula Ludovico16,17, Manuel Jurado1,2,3, Yang Li20,22, Pedro Sánchez-Rovira5, Mihai G Netea20,23, Andrea Gsur18, Pavel Vodička11,12,13, Víctor Moreno10, Kari Hemminki7,24,25, Hermann Brenner19,26,27, Jenny Chang-Claude28,29, Asta Försti7,30,31.
Abstract
The role of genetic variation in autophagy-related genes in modulating autophagy and cancer is poorly understood. Here, we comprehensively investigated the association of autophagy-related variants with colorectal cancer (CRC) risk and provide new insights about the molecular mechanisms underlying the associations. After meta-analysis of the genome-wide association study (GWAS) data from four independent European cohorts (8006 CRC cases and 7070 controls), two loci, DAPK2 (p = 2.19 × 10-5) and ATG5 (p = 6.28 × 10-4) were associated with the risk of CRC. Mechanistically, the DAPK2rs11631973G allele was associated with IL1 β levels after the stimulation of peripheral blood mononuclear cells (PBMCs) with Staphylococcus aureus (p = 0.002), CD24 + CD38 + CD27 + IgM + B cell levels in blood (p = 0.0038) and serum levels of en-RAGE (p = 0.0068). ATG5rs546456T allele was associated with TNF α and IL1 β levels after the stimulation of PBMCs with LPS (p = 0.0088 and p = 0.0076, respectively), CD14+CD16- cell levels in blood (p = 0.0068) and serum levels of CCL19 and cortisol (p = 0.0052 and p = 0.0074, respectively). Interestingly, no association with autophagy flux was observed. These results suggested an effect of the DAPK2 and ATG5 loci in the pathogenesis of CRC, likely through the modulation of host immune responses.Entities:
Keywords: autophagy; colorectal cancer; genetic variants; susceptibility
Year: 2021 PMID: 33809172 PMCID: PMC7998818 DOI: 10.3390/cancers13061258
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639